Kirk Brown

Enthusiast
DISC Type : i

Vice President, Research at Alnylam Pharmaceuticals

Cambridge, Massachusetts, United States

Overview

Kirk Brown is the Vice President of Research at Alnylam Pharmaceuticals, where he leads the Central Nervous System (CNS) research group. With a Ph. D. from the University of Vermont, he has risen through the ranks at Alnylam, spearheading the development of RNAi therapeutics for neurological diseases.

His teams preclinical work was instrumental in delivering RNAi therapeutics to the brain, leading to Alnylams first clinical program for the CNS.

Personality Overview

Optimistic

Non-Confrontational

Amiable & Agreeable

They agree with others often, so exercise caution when relying on their word.  They prefer to build relationships rather than staying totally transactional. Unlike D or C types, they are convinced more by stories and testimonials.

Topics They Care About

CNS Drug Development
He leads the CNS research team and is the research lead for ALN-APP, the first clinical CNS RNAi therapeutic program at Alnylam.
RNAi Therapeutics
His entire focus is on advancing Alnylam's core RNAi platform, specifically finding innovative ways to apply it to previously hard-to-reach tissues like the brain.
Treating Alzheimer's
He frequently discusses his team's work on an investigational RNAi therapeutic targeting the amyloid precursor protein (APP) for early-onset Alzheimer's disease.

Media Appearances

Kirk has no verified media appearances

Work History

8-2023
Vice President, Research at Alnylam Pharmaceuticals
4-2021 - 7-2023
Senior Director, CNS Research at Alnylam Pharmaceuticals
2-2019 - 3-2021
Director, CNS Early Development at Alnylam Pharmaceuticals
7-2017 - 1-2019
Associate Director at Alnylam Pharmaceuticals
3-2016 - 6-2017
Principal Scientist at Alnylam Pharmaceuticals

Education

2003 - 2005
Post-Doctoral Fellow from UMass Chan Medical School
1997 - 2003
Ph.D from University of Vermont

More Information

Social Presence :

Prographics :

Exp : 20 Location : Cambridge, Massachusetts, United States Job Level : Senior Designation : Vice President, Research at Alnylam Pharmaceuticals
URL has been copied!

Insights For Selling To Kirk

During A Call Or A Meeting

DO's

  • Invite them for a lunch or a drink/coffee
  • Compliment them about their personality if you get a chance
  • Ask them how their day is going or exchange some other pleasantries

DONT's

  • Avoid overloading them with too much information
  • Don't be critical or challenge them openly, they can react defensively
  • Don’t push them for a direct ‘no’, take lack of ‘yes’ as ‘no’ after some time

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Kirk is

  • Relationship and rapport are valuable for them, but so is proven product value.
  • Will you ever get a clear answer from Kirk

  • They probably won't say no directly.


Insights For Deal Planning

    How fast (or slow) will Kirk move?

  • They are not the ones to make fast decisions, even while they stay committed.
  • Can Kirk take some risk or not?

  • They can take some low-probability risks if needed.

You And Kirk

Personality Compatibility


Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.